small molecule

AURYXIA

FERRIC CITRATE

Loss of exclusivityJuly 2030latest FDA-listed patent expiry

CompanyKeryx Biopharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand name	AURYXIA
Active ingredient	FERRIC CITRATE
Strength	EQ 210MG IRON
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	September 2014
Marketing status	RX

Listed patents

Patent	Expires	Type
10300039	July 2030	use U-2549
9387191	July 2030	product
8093423	April 2026	use U-1577

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.